OxenFree Capital LLC
- SEC CIK
- 0002009781
- Latest filing
- Jul 8, 2026
The latest 13F from OxenFree Capital LLC covers Q2 2026 (filed Jul 8, 2026): 56 long positions worth $218.2M. The top 10 holdings make up 73.5% of the portfolio, and the largest is Ea Series Trust at 20.9%. Livermore has 11 filings on Form 13F from this institution, going back to Q4 2023.
What changed in Q2 2026
Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.
- New
- 4
- Est. +$2.94M
- Added
- 26
- Est. +$10.1M
- Reduced
- 21
- Est. −$10.3M
- Sold out
- 4
- Est. −$1.03M
Top 5 holdings
Share of this quarter's portfolio value
- Ea Series Trust02072L68020.9%$45.5M
- Ea Series Trust02072L61512.9%$28.1M
- Ea Series Trust02072L4587.6%$16.6M
- Ea Series Trust02072L5737.1%$15.6M
- Ea Series Trust02072L5815.1%$11.2M
Share of portfolio
Top 5 holdings and the other 51 positions, by share of portfolio value
- Ea Series Trust20.9%
- Ea Series Trust12.9%
- Ea Series Trust7.6%
- Ea Series Trust7.1%
- Ea Series Trust5.1%
- Other 51 positions46.4%
Biggest buys
New and added positions, by estimated amount bought
- Ea Series Trust02072L441+$3.43MAdded
- Vanguard Ftse Developed Markets ETF921943858+$2.28MAdded
- Invesco Nasdaq 100 ETF46138G649+$1.82MNew
- Ea Series Trust02072L573+$1.30MAdded
- Pacer FDS Tr69374H311+$681.8KNew
Largest weight increases
New and added positions, by percentage points of the portfolio gained
- Ea Series Trust02072L441+1.44 pp2.3% → 3.7%
- Vanguard Ftse Developed Markets ETF921943858+0.96 pp3.2% → 4.2%
- Invesco Nasdaq 100 ETF46138G649+0.83 pp0.0% → 0.8%
- Ea Series Trust02072L573+0.75 pp6.4% → 7.1%
- Ea Series Trust02072L680+0.46 pp20.4% → 20.9%
Biggest sells
Reduced and sold-out positions, by estimated amount sold
- Ea Series Trust02072L581−$2.28MReduced
- iShares Tr46434V456−$2.17MReduced
- Invesco QQQ Trust Series I46090E103−$1.88MReduced
- Ea Series Trust02072L458−$1.76MReduced
- Franklin Templeton ETF Tr35473P108−$566.8KReduced
Largest weight decreases
Reduced and sold-out positions, by percentage points of the portfolio lost
- Ea Series Trust02072L458−1.52 pp9.1% → 7.6%
- iShares Tr46434V456−1.17 pp3.7% → 2.5%
- Ea Series Trust02072L581−1.12 pp6.3% → 5.1%
- Invesco QQQ Trust Series I46090E103−0.77 pp1.7% → 0.9%
- Franklin Templeton ETF Tr35473P108−0.30 pp1.0% → 0.7%
Metrics
13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.
- Portfolio value
- $218.2M
- +$11.9M (+5.8%) vs. prior quarter
- Positions
- 56
- 0 vs. prior quarter
- Top 10 concentration
- 73.5%
- Top 10 as share of value
- Turnover
- 5.3%
- Q2 2026, one quarter
- Average holding period
- 9.9 quarters
- Weighted by value
How these are calculated
- Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
- Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
- Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
- Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q4 2023), so positions held before then are understated.
13F filings by quarter
11 quarters, going back to Q4 2023. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.
Peak $218.2M (Q2 2026)
| Quarter | Filed | Positions | Value | Top 3 holdings | Changes | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 8, 2026 | 56 | $218.2M | Ea Series TrustEa Series TrustEa Series Trust | vs. Q1 2026 | SEC |
| Q1 2026 | Apr 16, 2026 | 56 | $206.2M | Ea Series TrustEa Series TrustEa Series Trust | vs. Q4 2025 | SEC |
| Q4 2025 | Jan 15, 2026 | 48 | $190.2M | Ea Series TrustEa Series TrustEa Series Trust | vs. Q3 2025 | SEC |
| Q3 2025 | Oct 9, 2025 | 47 | $181.8M | Ea Series TrustEa Series TrustEa Series Trust | vs. Q2 2025 | SEC |
| Q2 2025 | Jul 11, 2025 | 45 | $162.4M | Ea Series TrustEa Series TrustEa Series Trust | vs. Q1 2025 | SEC |
| Q1 2025 | Apr 22, 2025 | 42 | $131.4M | Ea Series TrustEa Series TrustEa Series Trust | vs. Q4 2024 | SEC |
| Q4 2024 | Jan 23, 2025 | 42 | $133.1M | Ea Series TrustEa Series TrustEa Series Trust | vs. Q3 2024 | SEC |
| Q3 2024 | Oct 10, 2024 | 40 | $127.4M | Ea Series TrustEa Series TrustEa Series Trust | vs. Q2 2024 | SEC |
| Q2 2024 | Jul 18, 2024 | 39 | $114.5M | Ea Series TrustEa Series TrustEa Series Trust | vs. Q1 2024 | SEC |
| Q1 2024 | Apr 22, 2024 | 41 | $109.5M | Ea Series TrustEa Series TrustEa Series Trust | vs. Q4 2023 | SEC |
| Q4 2023 | Jan 29, 2024 | 38 | $97.3M | Ea Series TrustEa Series TrustEa Series Trust | – | SEC |